Granza Bio Secures $7M+ Seed Funding to Propel Advanced Cancer Treatments and Genetic Medicines
Granza Bio Corporation, a trailblazing biotechnology firm rooted in pioneering therapeutic delivery platforms, has successfully concluded an oversubscribed $7.14 million Seed funding round. The funding was led by prominent investors including Felicis and Refactor, alongside participation from Y Combinator and a consortium of esteemed angel investors. Established in 2024 by distinguished researchers from the University…